FDA recall, , High risk
MFV Compounding Pharmacy Diclofenac Sodium Eye Ointment
Diclofenac Sodium 0.1% Eye Ointment contains Bacillus cereus.
Summary by Recall Canary from the FDA notice
What happened
MFV COMPOUNDING PHARMACY began a recall of Diclofenac Sodium 0.1% Eye Ointment, 1.000 GM per tube, on June 9, 2026, because the product contains Bacillus cereus. The recall covers 54 tubes and was added to the FDA's Enforcement Report on June 26, 2026, and in the FDA's weekly enforcement report on July 8, 2026. The FDA classified the recall on July 21, 2026. The product was distributed in Alabama, Colorado, Florida, Georgia, Indiana, Maryland, Missouri and Washington.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is your tube affected?
Affected if its lot code matches.
Diclofenac Sodium 0.1% Eye Ointment, 5.000 GM per tube
- Lot code
- 19926
Recall details
- Company began the recall
- Company
- MFV COMPOUNDING PHARMACY
- Hazard
- Contamination
- Risk
High risk
There is a reasonable chance it could cause serious health problems or death in animals it is used on.
FDA Class I recall · How risk is rated
- Event ID
- 99305
- Recall number
- V-0181-2026
- Quantity recalled
- 54 tubes
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
Classified by FDA
Summary updated
